Burcon Announces Technology Breakthrough - Introduces New CLARISOY(TM) - Soy Protein Isolate

Vancouver, Canada, November 4 (ots/PRNewswire) - Burcon NutraScience
Corporation (TSX-V: BU) announces today that it has developed a
revolutionary soy protein isolate. Burcon has branded this new soy
protein isolate as CLARISOY(TM).

CLARISOY(TM) is 100% soluble and transparent in acidic solutions,
enabling applications down to pH 2.5. CLARISOY(TM) also has
exceptional flavour characteristics and is heat stable permitting hot
fill applications. Burcon's CLARISOY(TM) shows great promise for use
in a variety of healthy and great tasting food and beverage
applications and is expected to be price competitive as well which
should be of great interest to food and beverage manufacturers
currently dealing with high dairy protein prices.

Plant proteins represent an inexpensive and environmentally sound
source of functional and nutritious food ingredients. Plant proteins
have long been used as an indirect source of protein for humans
through their use as a feed ingredient for cattle, pigs and chickens.
Today, plant proteins can be grown, isolated and purified, converting
them to high value food ingredients for human consumption at a
fraction of the environmental and economic cost of animal proteins.

"For the past ten years, Burcon has focused its efforts on
developing the world's first commercial canola proteins, Puratein(R)
and Supertein(TM). Today's announcement demonstrates Burcon's ability
to leverage our talented team of scientists and engineers to exploit
a second major opportunity. That opportunity is the existing
multi-billion dollar global soy protein market," said Johann F.
Tergesen, Burcon's President and C.O.O. adding, "Our new CLARISOY(TM)
soy protein isolate product and the associated extraction technology
offer another major platform for Burcon to earn revenue and to pursue
future opportunities."

Burcon also announces today that it has filed patent applications
with the United States Patent and Trademark Office to protect its
newly developed novel processes for the production of plant proteins
including acid soluble soy protein isolates, as well as to protect
CLARISOY(TM), the product derived there from, and to protect the
functional and nutritional applications of CLARISOY(TM) as an
ingredient in foods and beverages. Consistent with Burcon's previous
patents and patent applications, Burcon will also file for protection
internationally under the patent cooperation treaty of the World
Intellectual Property Organization to protect these new inventions.
As at the date of this announcement, Burcon now has 68 issued patents
worldwide, and well in excess of 200 additional patent applications,
including 8 issued U.S. patents and 48 U.S. patent applications.

About Burcon NutraScience

Burcon is a research and development company developing a
portfolio of composition, application, and process patents around its
plant protein extraction and purification technology. The goal of
Burcon's research is to develop its patented process to utilize
inexpensive oilseed meals for the production of purified plant
proteins that exhibit valuable nutritional, functional or
nutraceutical profiles. Burcon, in conjunction with Archer Daniels
Midland, is currently focusing its efforts on developing the world's
first commercial canola proteins, Puratein(R) and Supertein(TM).
Canola, recognized for its nutritional qualities, is the
second-largest oilseed crop in the world after soybeans. Burcon's
goal is to develop Puratein(R) and Supertein(TM) to participate with
soy, dairy, and egg proteins in the expanding multi-billion-dollar
protein ingredient market, with potential uses in prepared foods,
nutritional supplements, and personal care products.

ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
President & Chief Operating Officer

The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information
contained herein. This press release contains forward-looking
statements that involve risks and uncertainties. These
forward-looking statements relate to, among other things, plans and
timing for the introduction or enhancement of our products,
statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in
this press release that are not historical fact. Our expectations
regarding the prospect for future success depend upon our ability to
develop and sell products, which we do not produce today and cannot
be sold without further research and development. When used in this
press release, the words "goal," "intend," "believes" and "potential"
and similar expressions, generally identify forward-looking
statements. These statements reflect our current expectations. They
are subject to a number of risks and uncertainties. In light of the
many risks and uncertainties surrounding the development of a source
of protein from canola meal, you should understand that we cannot
assure you that the forward-looking statements contained in this
press release will be realized.

For further information: Jade Cheng, Chief Financial Officer,
Burcon NutraScience Corporation, +1-604-733-0896, +1-888-408-7960
toll-free, jcheng@burcon.ca, http://www.burcon.ca; AXINO AG, Sven
Olsson, Investor Relations Europe, Konigstrasse 26, 70173 Stuttgart,
Germany, Tel. +49-711-25-35-92-30, Fax +49-711-25-35-92-33,
olsson@axino.de, http://www.burcon.net

ots Originaltext: Burcon NutraScience Corporation
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, +1-604-733-0896, +1-888-408-7960 toll-free,
jcheng@burcon.ca; AXINO AG, Sven Olsson, Investor Relations Europe,
Konigstrasse 26, 70173 Stuttgart, Germany, Tel. +49-711-25-35-92-30,
Fax +49-711-25-35-92-33, olsson@axino.de